UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Gilbert & Cook Inc.

Gilbert & Cook Inc. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 238.0% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,555 shares of the healthcare conglomerate’s stock after acquiring an additional 1,095 shares during the period. Gilbert & Cook Inc.’s holdings in UnitedHealth Group were worth $909,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at approximately $27,000. Macroview Investment Management LLC boosted its stake in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $31,000. Global Wealth Strategies & Associates lifted its stake in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the last quarter. Finally, Signature Resources Capital Management LLC lifted its stake in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 0.2 %

Shares of UnitedHealth Group stock opened at $592.23 on Friday. The firm has a market cap of $545.02 billion, a price-to-earnings ratio of 38.58, a P/E/G ratio of 1.74 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a 50-day simple moving average of $582.84 and a 200-day simple moving average of $549.52.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period in the previous year, the company earned $6.56 EPS. The firm’s revenue was up 9.2% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Stephens dropped their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th. UBS Group dropped their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Finally, KeyCorp initiated coverage on UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price on the stock. Three research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.